Redhill Biopharma

$8.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.42 (-4.78%) Today
$0.00 (0.00%) As of 4:32 AM EST after-hours

Why Robinhood?

You can buy or sell RDHL and other stocks, options, and ETFs commission-free!

About RDHL

Redhill Biopharma Ltd. American Depositary Shares, also called Redhill Biopharma, is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company’s subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel. The listed name for RDHL is Redhill Biopharma Ltd. American Depositary Shares.

CEO
Dror Ben-Asher
Employees
Headquarters
Tel Aviv, Tel Aviv
Founded
2009
Market Cap
313.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
377.04K
High Today
$8.81
Low Today
$8.26
Open Price
$8.81
Volume
301.12K
52 Week High
$11.35
52 Week Low
$3.26

Collections

RDHL News

BenzingaNov 20

Why RedHill Biopharma's Stock Is Trading Higher Today

RedHill Biopharma (NASDAQ: RDHL) shares are trading higher on Friday after the company reported the initiation of its Phase 3 study of RHB-204 for first-line tr

RDHL Earnings

-$0.38
-$0.24
-$0.11
$0.03
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.16 per share
Actual
-$0.05 per share

You May Also Like